Below you'll find a list of trials that we know are currently recruiting sarcoma patients in the UK. We update this list regularly, so it's worth coming back if you don't immediately find a trial that is appropriate for you. 

We aim to feature all trials for sarcoma patients on our Find a Trial page. However, there may be phase 1 trials recruiting patients from a range of different cancer types, which may accept sarcoma patients. For more information on the availability of these trials talk to your clinical team.

Disclaimer: Trials listed on our site are not endorsed by Sarcoma UK. The decision about whether to join a trial is your own. We offer signposting to appropriate trials, however we are unable to say whether you will ultimately be eligible to take part. Sarcoma UK is unable to refer you directly to a trial. Please discuss trials with your clinical team.  
 
The safety and validity of each trial is the responsibility of its sponsor (the company/body that funds it) and its investigators (the clinicians and researchers running the trial) and not of Sarcoma UK. The information we provide is limited, and does not include all details relevant to participation in a trial. We aim to provide accurate and up to date trial information, however we rely on sources outside of Sarcoma UK to do this. 

Sarcoma Type: 
Chordoma

This study aims to find out more about how chordoma develops, how and why it progresses, and its response to established and to new treatments.

Sarcoma Type:

Epithelioid sarcoma

This study compares the drugs tazemetostat and doxorubicin to the current front-line standard treatment, single-agent doxorubicin and placebo

Sarcoma Type:

Sarcomas with specific genetic markers or mutations 

This study aims to find out how effective erdafitinib is in terms of overall response rate (ORR) in patients with advanced solid tumors with fibroblast growth factor receptor (FGFR) mutations and gene fusions.

Sarcoma Type: 
Synovial sarcoma

This study aims to find out how safe the drug ADP-A2M4 is and how effective it is at attacking synovial sarcoma or Myxoid/Round Cell Liposarcoma cancer cells.

Sarcoma Type:

Sarcomas with specific genetic markers or mutations 

This study aims to find out how safe and effective the drug IMCnyeso is when given to patients with NY-ESO-1 and/or LAGE-A1 positive tumours.

Sarcoma Type: 
Ewing's sarcoma

This study compares four different chemotherapy treatments for Ewing's sarcoma which cannot be removed by surgery or has returned after initial treatment.

Sarcoma Type: 
Osteosarcoma

This study aims to find out how safe and effective the drug Lenvatinib with Ifosfamide and Etoposide is, compared to Ifosfamide and Etoposide alone.

Sarcoma Type: 
Synovial sarcoma

This study aims to find out how safe and effective GSK3377794 is in treating synovial sarcoma.

Sarcoma Type: 
Osteosarcoma

The aim of this project is to collect high quality clinical data about patients of all ages with osteosarcoma.

Sarcoma Type:

Undifferentiated uterine sarcoma

This study aims to find out whether the drug cabozantinib can be used to maintain the effects of previous chemotherapy using doxorubicin and ifosfamide on a longer term basis,  for sarcoma of the womb that has spread or cannot be treated with surgery.

Pages